-+ 0.00%
-+ 0.00%
-+ 0.00%

Austar Lifesciences sees H1 profit attributable to owners at RMB 8 million-RMB 10 million

PUBT·07/30/2026 08:53:49
Listen to the news
Austar Lifesciences sees H1 profit attributable to owners at RMB 8 million-RMB 10 million
  • Austar Lifesciences guided for profit attributable to owners of RMB 8-10 million for the six months ended June 30, 2026.
  • That compares with RMB 25 million a year earlier, implying a drop of about 60%-68%.
  • Drivers cited include no repeat of RMB 11.4 million one-off exchange gains, lower gross margin on strategic projects, higher market-promotion spending.
  • Interim results for the period are expected in late August 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Austar Lifesciences Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260730-12261717), on July 30, 2026, and is solely responsible for the information contained therein.